Tanja Hakkarainen

1.7k total citations
36 papers, 1.4k citations indexed

About

Tanja Hakkarainen is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Tanja Hakkarainen has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 29 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Tanja Hakkarainen's work include Virus-based gene therapy research (33 papers), RNA Interference and Gene Delivery (17 papers) and CAR-T cell therapy research (15 papers). Tanja Hakkarainen is often cited by papers focused on Virus-based gene therapy research (33 papers), RNA Interference and Gene Delivery (17 papers) and CAR-T cell therapy research (15 papers). Tanja Hakkarainen collaborates with scholars based in Finland, United States and France. Tanja Hakkarainen's co-authors include Akseli Hemminki, Anna Kanerva, Jarmo Wahlfors, Renée A. Desmond, David T. Curiel, Merja Särkioja, Gerd Bauerschmitz, Petri Lehenkari, Kilian Guse and Tuuli Ranki and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Tanja Hakkarainen

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanja Hakkarainen Finland 23 949 847 639 247 168 36 1.4k
Ángel A. Rivera United States 24 1.1k 1.1× 1.1k 1.3× 737 1.2× 214 0.9× 293 1.7× 46 1.7k
Manel Cascalló Spain 25 1.2k 1.3× 865 1.0× 906 1.4× 311 1.3× 56 0.3× 49 1.5k
Yosuke Kawakami Japan 19 617 0.7× 556 0.7× 468 0.7× 108 0.4× 119 0.7× 42 1.1k
Zeng B. Zhu United States 24 776 0.8× 823 1.0× 552 0.9× 157 0.6× 157 0.9× 45 1.4k
Rafael Moreno Spain 20 628 0.7× 491 0.6× 636 1.0× 175 0.7× 144 0.9× 49 1.2k
Matthew A. Tyler United States 16 543 0.6× 626 0.7× 450 0.7× 103 0.4× 216 1.3× 29 1.0k
Jacqueline N. Parker United States 17 1.1k 1.2× 643 0.8× 854 1.3× 123 0.5× 143 0.9× 24 1.5k
Kilian Guse Finland 22 781 0.8× 717 0.8× 570 0.9× 226 0.9× 30 0.2× 32 1.3k
Toshihiro Mineta Japan 22 1.2k 1.2× 984 1.2× 736 1.2× 140 0.6× 212 1.3× 53 2.1k
R C Moen United States 13 1.2k 1.3× 1.2k 1.4× 699 1.1× 98 0.4× 155 0.9× 20 2.3k

Countries citing papers authored by Tanja Hakkarainen

Since Specialization
Citations

This map shows the geographic impact of Tanja Hakkarainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Hakkarainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Hakkarainen more than expected).

Fields of papers citing papers by Tanja Hakkarainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Hakkarainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Hakkarainen. The network helps show where Tanja Hakkarainen may publish in the future.

Co-authorship network of co-authors of Tanja Hakkarainen

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Hakkarainen. A scholar is included among the top collaborators of Tanja Hakkarainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Hakkarainen. Tanja Hakkarainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pietilä, Mika, et al.. (2014). Mesenchymal Stromal Cells from Female Donors Enhance Breast Cancer Cell Proliferation in vitro. Oncology. 88(4). 214–225. 9 indexed citations
2.
Rajecki, Maria, Mirkka Sarparanta, Tanja Hakkarainen, et al.. (2012). SPECT/CT Imaging of hNIS -Expression after Intravenous Delivery of an Oncolytic Adenovirus and 131I. PLoS ONE. 7(3). e32871–e32871. 21 indexed citations
3.
Liikanen, Ilkka, Vladia Monsurrò, Laura Ahtiainen, et al.. (2011). Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus. Molecular Therapy. 19(10). 1858–1866. 39 indexed citations
4.
Dias, João D., Ilkka Liikanen, Kilian Guse, et al.. (2010). Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1. Clinical Cancer Research. 16(9). 2540–2549. 36 indexed citations
5.
Hakkarainen, Tanja, Maria Rajecki, Mirkka Sarparanta, et al.. (2009). Targeted Radiotherapy for Prostate Cancer with an Oncolytic Adenovirus Coding for Human Sodium Iodide Symporter. Clinical Cancer Research. 15(17). 5396–5403. 33 indexed citations
6.
Särkioja, Merja, Tanja Hakkarainen, Minna Eriksson, et al.. (2008). The cyclo‐oxygenase 2 promoter is induced in nontarget cells following adenovirus infection, but an AU‐rich 3′‐untranslated region destabilization element can increase specificity. The Journal of Gene Medicine. 10(7). 744–753. 2 indexed citations
7.
Eriksson, Minna, Kilian Guse, Gerd Bauerschmitz, et al.. (2007). Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44+CD24–/Low Cells. Molecular Therapy. 15(12). 2088–2093. 83 indexed citations
8.
Ranki, Tuuli, Merja Särkioja, Tanja Hakkarainen, et al.. (2007). Systemic efficacy of oncolytic adenoviruses in imagable orthotopic models of hormone refractory metastatic breast cancer. International Journal of Cancer. 121(1). 165–174. 36 indexed citations
9.
Mättö, Mikko, et al.. (2006). hCAR-EGFP fusion receptor in human follicular lymphoma B cells - A model for adenoviral gene therapy for B cell malignancies. International Journal of Molecular Medicine. 17(6). 1057–62. 5 indexed citations
10.
Särkioja, Merja, Anna Kanerva, Jarmo Salo, et al.. (2006). Noninvasive imaging for evaluation of the systemic delivery of capsid‐modified adenoviruses in an orthotopic model of advanced lung cancer. Cancer. 107(7). 1578–1588. 29 indexed citations
11.
Bauerschmitz, Gerd, Kilian Guse, Anna Kanerva, et al.. (2006). Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells. Molecular Therapy. 14(2). 164–174. 55 indexed citations
12.
Lehmusvaara, Saara, Tuula Salonen, Tanja Hakkarainen, et al.. (2006). Type I interferon response against viral and non‐viral gene transfer in human tumor and primary cell lines. The Journal of Gene Medicine. 9(2). 122–135. 17 indexed citations
13.
Wahlfors, Tiina, Tanja Hakkarainen, Juhani Jänne, Leena Alhonen, & Jarmo Wahlfors. (2005). In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition. International Journal of Cancer. 118(11). 2907–2910. 4 indexed citations
14.
Hakkarainen, Tanja, et al.. (2005). VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22‐HSVTk‐GFP triple fusion construct. The Journal of Gene Medicine. 7(7). 898–907. 19 indexed citations
15.
Hakkarainen, Tanja, Anna Kanerva, & Akseli Hemminki. (2005). [Adenoviruses in cancer therapy].. PubMed. 121(20). 2195–203.
16.
Hakkarainen, Tanja, et al.. (2005). HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct. International Journal of Oncology. 27(1). 203–8. 11 indexed citations
17.
Pellinen, Riikka, et al.. (2004). Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy. International Journal of Oncology. 25(6). 1753–62. 40 indexed citations
18.
Hemminki, Akseli, Minghui Wang, Tanja Hakkarainen, et al.. (2003). Production of an EGFR targeting molecule from a conditionally replicating adenovirus impairs its oncolytic potential. Cancer Gene Therapy. 10(8). 583–588. 24 indexed citations
19.
Kanerva, Anna, Kurt R. Zinn, Tandra R. Chaudhuri, et al.. (2003). Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular Therapy. 8(3). 449–458. 143 indexed citations
20.
Barker, Shannon, Anna Kanerva, Tanja Hakkarainen, et al.. (2002). The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy. The Journal of Gene Medicine. 5(4). 300–310. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ángel A. Rivera Breakdown of academic impact, for papers by Manel Cascalló Breakdown of academic impact, for papers by Yosuke Kawakami Breakdown of academic impact, for papers by Zeng B. Zhu Breakdown of academic impact, for papers by Rafael Moreno Breakdown of academic impact, for papers by Matthew A. Tyler Breakdown of academic impact, for papers by Jacqueline N. Parker Breakdown of academic impact, for papers by Kilian Guse Breakdown of academic impact, for papers by Toshihiro Mineta Breakdown of academic impact, for papers by R C Moen
Rankless by CCL
2026